Related references
Note: Only part of the references are listed.Drug sensitivity prediction by CpG island methylation profile in the NCI-60 cancer cell line panel
Lanlan Shen et al.
CANCER RESEARCH (2007)
Evaluation of matrix metalloproteinase 7 in plasma and pancreatic juice as a biomarker for pancreatic cancer
Koert F. D. Kuhlmann et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Gene Expression Patterns in Pancreatic Tumors, Cells and Tissues
Anson W. Lowe et al.
PLOS ONE (2007)
Cancer epigenomics: DNA methylomes and histone-modification maps
Manel Esteller
NATURE REVIEWS GENETICS (2007)
An in vivo platform for translational drug development in pancreatic cancer
Belen Rubio-Viqueira et al.
CLINICAL CANCER RESEARCH (2006)
Role of the glutathione metabolic pathway in lung cancer treatment and prognosis: A review
P Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer
A Jimeno et al.
MOLECULAR CANCER THERAPEUTICS (2006)
High-throughput DNA methylation profiling using universal bead arrays
M Bibikova et al.
GENOME RESEARCH (2006)
The tyrosine kinase inhibitor imatinib fails to inhibit pancreatic cancer progression
J Chen et al.
CANCER LETTERS (2006)
The epigenetic progenitor origin of human cancer
AP Feinberg et al.
NATURE REVIEWS GENETICS (2006)
Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy
E Rosenbaum et al.
CLINICAL CANCER RESEARCH (2005)
Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis
C Scholz et al.
ANNALS OF HEMATOLOGY (2005)
Hypermethylation of CpG islands in primary and metastatic human prostate cancer
S Yegnasubramanian et al.
CANCER RESEARCH (2004)
Java Treeview-extensible visualization of microarray data
AJ Saldanha
BIOINFORMATICS (2004)
Open source clustering software
MJL de Hoon et al.
BIOINFORMATICS (2004)
Promoter-dependent mechanism leading to selective hypomethylation within the 5′ region of gene MAGE-A1 in tumor cells
C De Smet et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Mechanisms of disease: Gene silencing in cancer in association with promoter hypermethylation
JG Herman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
The power and the promise of DNA methylation markers
PW Laird
NATURE REVIEWS CANCER (2003)
Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays
CA Iacobuzio-Donahue et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Significant reduction of WT1 gene expression, possibly due to epigenetic alteration in Wilms' tumor
Y Satoh et al.
JOURNAL OF BIOCHEMISTRY (2003)
The fundamental role of epigenetic events in cancer
PA Jones et al.
NATURE REVIEWS GENETICS (2002)
Discovery of novel tumor markers of pancreatic cancer using global gene expression technology
CA Iacobuzio-Donahue et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Induction and expression of cyclin D3 in human pancreatic cancer
MPA Ebert et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2001)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
